1 Day
Source:
Sharjah24
Emirates for Medicine launches Etkamah for breast cancer
The Emirates Foundation for Medicine has approved the drug "Ectamame" from AstraZeneca. It is an oral treatment intended for patients with advanced or metastatic breast cancer who have developed an ESR1 gene mutation during hormonal therapy, making the UAE the first country worldwide to offer this treatment option. The drug is used in combination with CDK4/6 inhibitors and is based on the active substance Camizestrant, which works to inhibit estrogen receptors to improve treatment outcomes. This approval comes as part of the country's efforts to enhance therapeutic options and develop the healthcare system.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)